A 59-year-old with HFrEF (LVEF 25%) on ACE inhibitor, evidence-based β-blocker, and spironolactone remains NYHA II. Diabetes status is negative. What ...

Question

A 59-year-old with HFrEF (LVEF 25%) on ACE inhibitor, evidence-based β-blocker, and spironolactone remains NYHA II. Diabetes status is negative. What additional therapy improves morbidity and mortality regardless of diabetes?

Accepted Answer

Add an SGLT2 inhibitor

Answer

Start diltiazem

Answer

Initiate NSAID for pain control

Answer

Begin an alpha-1 blocker

Answer

Stop the ACE inhibitor

us-abim MCQ (SBA): Heart Failure (HFrEF)

A 59-year-old with HFrEF (LVEF 25%) on ACE inhibitor, evidence-based β-blocker, and spironolactone remains NYHA II. Diabetes status is negative. What additional therapy improves morbidity and mortality regardless of diabetes?